S201: FINAL 7-YEAR FOLLOW UP AND RETREATMENT SUBSTUDY ANALYSIS OF MURANO: VENETOCLAX-RITUXIMAB (VENR)-TREATED PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (R/R CLL)

• Arnon Kater,
• Rosemary Harrup,
• Thomas J Kipps,
• Barbara Eichhorst,
• Carolyn J Owen,
• Sarit Assouline,
• Nicole Lamanna,
• Tadeusz Robak,
• Javier de la Serna,
• Ulrich Jaeger,
• Guillaume Cartron,
• Marco Montillo,
• Clemens Mellink,
• Brenda Chyla,
• Maria Thadani-Mulero,
• Marcus Lefebure,
• Yanwen Jiang,
• Rosemary Millen,
• Michelle Boyer,
• John F Seymour

Affiliations

Arnon Kater

1 Amsterdam University Medical Centers, Amsterdam, The Netherlands

Rosemary Harrup

2 Royal Hobart Hospital, University of Tasmania, Tasmania, Australia

Thomas J Kipps

3 UCSD Moores Cancer Center, San Diego, United States

Barbara Eichhorst

4 University of Cologne, Cologne, Germany

Carolyn J Owen

5 University of Calgary, Calgary, Canada

Sarit Assouline

6 Segal Cancer Center, Lady Davis Institute, Jewish General Hospital, Montreal, Canada

Nicole Lamanna

7 Columbia University Medical Center, New York, United States

Tadeusz Robak

8 Medical University of Lodz, Lodz, Poland

Javier de la Serna

9 Hospital Universitario 12 de Octubre, Madrid, Spain

Ulrich Jaeger

10 Medical University of Vienna, Vienna, Austria

Guillaume Cartron

11 Centre Hospitalier Universitaire de Montpellier, Montpellier, France

Marco Montillo

12 Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy

Clemens Mellink

1 Amsterdam University Medical Centers, Amsterdam, The Netherlands

Brenda Chyla

13 AbbVie, North Chicago, United States

Maria Thadani-Mulero

14 Roche Products Ltd., Welwyn Garden City, United Kingdom

Marcus Lefebure

14 Roche Products Ltd., Welwyn Garden City, United Kingdom

Yanwen Jiang

15 Genentech Inc., South San Francisco, United States

Rosemary Millen

14 Roche Products Ltd., Welwyn Garden City, United Kingdom

Michelle Boyer

14 Roche Products Ltd., Welwyn Garden City, United Kingdom

John F Seymour

16 Royal Melbourne Hospital, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Australia